{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70183-221",
      "generic_name": "sotagliflozin",
      "labeler_name": "Lexicon Pharmaceuticals, Inc.",
      "brand_name": "INPEFA",
      "active_ingredients": [
        {
          "name": "SOTAGLIFLOZIN",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70183-221-07",
          "description": "1 BLISTER PACK in 1 CARTON (70183-221-07)  / 7 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20240115",
          "sample": true
        },
        {
          "package_ndc": "70183-221-30",
          "description": "30 TABLET in 1 BOTTLE (70183-221-30)",
          "marketing_start_date": "20240301",
          "sample": false
        },
        {
          "package_ndc": "70183-221-31",
          "description": "1 BLISTER PACK in 1 CARTON (70183-221-31)  / 3 BLISTER PACK in 1 BLISTER PACK / 10 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20231201",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Lexicon Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "2638683",
          "2638689",
          "2638691",
          "2638693"
        ],
        "spl_set_id": [
          "1a46614e-05f6-421a-b6f4-d6f8760d643a"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0370183241300",
          "0370183221302",
          "0300000000001"
        ],
        "nui": [
          "N0000187059",
          "N0000187058",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "6B4ZBS263Y"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "2179079d-1c89-44b3-9b9c-2001d46310a1",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230526",
      "product_id": "70183-221_2179079d-1c89-44b3-9b9c-2001d46310a1",
      "application_number": "NDA216203",
      "brand_name_base": "INPEFA",
      "pharm_class": [
        "P-Glycoprotein Inhibitors [MoA]",
        "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
        "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}